API and Intermediate product
Active Pharmaceutical Ingredients (APIs)
GMP & WHO-GMP compliant pharmaceutical products
| Name | Grade | DMF | Accreditation | CAS No. | Status | Therapeutic Category |
|---|---|---|---|---|---|---|
| Apixaban | USP / IP / Ph. Eur | USFDA | GMP / WHO-GMP / FDA | 503612-47-3 | Under R&D | Anticoagulant (Factor Xa inhibitor) |
| Propofol | USP / IP / Ph. Eur | — | GMP / WHO-GMP | 2078-54-8 | Commercial | General anesthetic (IV sedative) |
| Ferric Chloride | IP / Ph. Eur | — | GMP | 7705-08-0 | Commercial | Hematinic / Chemical reagent |
| Bilastine | USP / Ph. Eur | USFDA | GMP / WHO-GMP / CEP | 202189-78-4 | Commercial | Antihistamine (H1 receptor antagonist) |
Apixaban
Grade: USP / IP / Ph. Eur
DMF: USFDA
Accreditation: GMP / WHO-GMP / FDA
CAS: 503612-47-3
Under R&D
Category: Anticoagulant
Propofol
Grade: USP / IP / Ph. Eur
Accreditation: GMP / WHO-GMP
CAS: 2078-54-8
Commercial
Category: General anesthetic
Ferric Chloride
Grade: IP / Ph. Eur
Accreditation: GMP
CAS: 7705-08-0
Commercial
Category: Hematinic / Chemical reagent
Bilastine
Grade: USP / Ph. Eur
Accreditation: GMP / WHO-GMP / CEP
CAS: 202189-78-4
Commercial
Category: Antihistamine
Key Starting Materials (KSM) / Intermediates
GMP compliant intermediates for pharmaceutical synthesis
| Name of Product | Grade | IUPAC Name | Accreditation | CAS No. | Product Status | Therapeutic Category / Application |
|---|---|---|---|---|---|---|
| 5-Bromo-7-azaindole | Research / Commercial | 5-bromo-1H-pyrrolo[2,3-b]pyridine | GMP (intermediate) | 183208-35-7 | Available | Scaffold for kinase inhibitor synthesis (oncology) |
| 4-Fluoro-3-nitrobenzonitrile | Research / Commercial | 4-fluoro-3-nitrobenzonitrile | GMP (intermediate) | 1009-35-4 | Under Development | Key intermediate in pharmaceutical synthesis |
| Bromopropiophenone | Research / Commercial | 1-bromo-1-phenylpropan-1-one | GMP (intermediate) | 34911-51-8 | Under Development | Pharmaceutical & fine chemical intermediate |
| Trimethylsulfoxonium bromide (TMSB) | Research / Commercial | Trimethylsulfoxonium bromide | GMP (intermediate) | 25596-24-1 | Under Pipeline | Reagent for epoxidation reactions |
| 2,6-Dichloroaniline | Research / Commercial | 2,6-dichloroaniline | GMP (intermediate) | 608-31-1 | Under Pipeline | Agrochemical & pharmaceutical intermediate |
| Imatinib base | Research / Commercial | 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide | GMP (intermediate) | 152459-95-5 | Under Pipeline | Final API for Imatinib synthesis |
5-Bromo-7-azaindole
Grade: Research / Commercial
IUPAC: 5-bromo-1H-pyrrolo[2,3-b]pyridine
CAS: 183208-35-7
Available
Application: Kinase inhibitor scaffold
4-Fluoro-3-nitrobenzonitrile
Grade: Research / Commercial
CAS: 1009-35-4
Under Development
Application: Pharmaceutical intermediate
Trimethylsulfoxonium bromide (TMSB)
CAS: 25596-24-1
Under Pipeline
Application: Epoxidation reagent
Imatinib Base
CAS: 152459-95-5
Under Pipeline
Application: Final API for Imatinib